Funded Tech Companies

Latigo Biotherapeutics

Latigo Biotherapeutics, based in Thousand Oaks, raised money from Alexandria Venture Investments, Blue Owl Capital and Kern Partners.

Company Overview

Contact Information

Company Background Information

Overview

We are a clinical-stage company developing innovative non-opioid pain medicines with best-in-class profiles. Reducing pain lowers stress and facilitates healing. There is a large unmet need for a new class of medicines to treat pain, as the standard of care for pain has remained unchanged for decades.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

3/17/2025

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Desmond Padhi

        

Vice President

Holly Carlisle

        

Vice President

Mike Kaufman

        

Vice President

Bryan Moyer

        

Company Investors

• Alexandria Venture Investments
• Blue Owl Capital (Kevin Raidy)
• Kern Partners
• Westlake Village BioPartners
• UPMC Enterprises
• Sanofi Ventures
• Access Biotechnology
• Rock Springs Capital
• Foresite Capital
• Deep Track Capital
• 5AM Ventures
• Cormorant Asset Management
• Qatar Investment Authority
• Corner Ventures

Browse more funded tech companies:

Latigent | Latii

Share this article

About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary